文献速递其他结缔组织病自身炎症与 IgG4 相关病

复发性多软骨炎的罕见遗传变异:一项全外显子组测序研究

Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing study.
PubMed 文献 · Ann Rheum Dis · 2024-01-11

该病例对照全外显子组罕见变异关联分析纳入66例无亲缘关系的欧美复发性多软骨炎(RP)患者和2923名健康对照,发现RP与DCBLD2基因超罕见损伤性变异负荷显著升高相关(7.6% vs 0.1%,未校正OR=79.8,p=2.93×10⁻⁷),RP患者血浆DCBLD2蛋白水平显著高于健康对照(中位4.06 ng/µL vs 0.05 ng/µL,p<0.001)。通路分析显示肿瘤坏死因子信号通路基因富集有统计学意义。作者认为DCBLD2罕见变异是RP的假定遗传风险因素,需在更多RP患者中验证并需未来功能实验支持。

要点

  • RP患者DCBLD2基因超罕见损伤性变异负荷显著高于健康对照(7.6% vs 0.1%,未校正OR=79.8,p=2.93×10⁻⁷)。
  • RP患者血浆DCBLD2蛋白水平显著高于健康对照(中位4.06 ng/µL vs 0.05 ng/µL,p<0.001)。
  • 肿瘤坏死因子信号通路基因富集有统计学意义,由RELB、RELA和REL的罕见损伤性变异驱动。

核心结论

  • 本研究将DCBLD2基因中的特定罕见变异确定为RP的假定遗传风险因素。
  • 作者认为这些发现应在更多RP患者中验证,并需未来功能实验支持。

研究设计与样本

  • 病例对照全外显子组罕见变异关联分析,纳入66例无亲缘关系的欧美RP患者和2923名健康对照。
  • 采用Firth逻辑回归进行基因水平 collapsing 分析。
  • 采用基因集富集分析、序列核关联检验和higher criticism检验三种方法进行探索性通路分析。
  • 采用ELISA测定RP患者和健康对照的血浆DCBLD2水平。

主要发现

  • 在collapsing分析中,RP与DCBLD2基因超罕见损伤性变异负荷显著升高相关(7.6% vs 0.1%,未校正OR=79.8,p=2.93×10⁻⁷)。
  • RP患者血浆DCBLD2蛋白水平显著高于健康对照(中位4.06 ng/µL vs 0.05 ng/µL,p<0.001)。
  • 通路分析显示肿瘤坏死因子信号通路基因富集有统计学意义,由RELB、RELA和REL的罕见损伤性变异驱动,采用经特征向量中心性加权的higher criticism检验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为这些发现应在更多RP患者中验证,并需未来功能实验支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Relapsing polychondritis (RP) is a systemic inflammatory disease of unknown aetiology. The objective of this study was to examine the contribution of rare genetic variations to RP. METHODS: We performed a case-control exome-wide rare variant association analysis that included 66 unrelated European American cases with RP and 2923 healthy controls (HC). Gene-level collapsing analysis was performed using Firth's logistics regression. Exploratory pathway analysis was performed using three different methods: Gene Set Enrichment Analysis, sequence kernel association test and higher criticism test. Plasma DCBLD2 levels were measured in patients with RP and HC using ELISA. RESULTS: In the collapsing analysis, RP was associated with a significantly higher burden of ultra-rare damaging variants in the DCBLD2 gene (7.6% vs 0.1%, unadjusted OR=79.8, p=2.93×10-7). Plasma DCBLD2 protein levels were significantly higher in RP than in HC (median 4.06 ng/µL vs 0.05 ng/µL, p<0.001). The pathway analysis revealed a statistically significant enrichment of genes in the tumour necrosis factor signalling pathway driven by rare damaging variants in RELB, RELA and REL using higher criticism test weighted by eigenvector centrality. CONCLUSIONS: This study identified specific rare variants in the DCBLD2 gene as a putative genetic risk factor for RP. These findings should be validated in additional patients with RP and supported by future functional experiments.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Luo Y, Ferrada MA, Sikora KA, et al. Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing study. Ann Rheum Dis. 2024. PMID: 37918895. doi:10.1136/ard-2023-224732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。